Bone filler injection in hip shows promise for pain relief

NCT ID NCT03494660

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study followed 77 people who had a procedure called Subchondroplasty for hip bone defects. Doctors injected a calcium phosphate bone filler into the damaged area. The goal was to see if it improved pain, movement, and daily activities over two years. Results were measured using standard hip scores and pain scales.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
calcium phosphate bone filler (AccuFill)
What this could lead to
If successful, this procedure could offer a minimally invasive option to reduce hip pain and improve function for people with certain bone defects.
What could go wrong
This is a small, completed study without a comparison group, so results may not apply to everyone. The procedure may not work for all types of hip problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AVASCULAR NECROSIS OF HIP are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Andrews Research & Education Foundation

    Gulf Breeze, Florida, 32561, United States

  • Cleveland Clinic Foundation

    Cleveland, Ohio, 44195, United States

  • Eisenhower Desert Orthopedic Center

    Rancho Mirage, California, 92270, United States

  • OrthoIllinois

    Rockford, Illinois, 61114, United States

  • The Ohio State University

    Columbus, Ohio, 43202, United States

  • University of Kentucky Research Foundation

    Lexington, Kentucky, 40506, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.